1832 Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $827K | Sell |
9,150
-650
| -7% | -$59.6K | ﹤0.01% | 554 |
|
|
2025
Q4 | $881K | Buy |
+9,800
| New | +$929K | ﹤0.01% | 584 |
|
|
2025
Q2 | – | Sell |
-15,469
| Closed | -$1.75M | – | 764 |
|
|
2025
Q1 | $1.75M | Sell |
15,469
-2,544
| -14% | -$272K | ﹤0.01% | 501 |
|
|
2024
Q4 | $1.9M | Buy |
18,013
+2,210
| +14% | +$237K | ﹤0.01% | 499 |
|
|
2024
Q3 | $1.71M | Sell |
15,803
-537
| -3% | -$58.6K | ﹤0.01% | 551 |
|
|
2024
Q2 | $1.77M | Buy |
16,340
+2,324
| +17% | +$274K | ﹤0.01% | 516 |
|
|
2024
Q1 | $1.85M | Buy |
14,016
+275
| +2% | +$34.4K | ﹤0.01% | 518 |
|
|
2023
Q4 | $1.67M | Sell |
13,741
-5,414
| -28% | -$604K | ﹤0.01% | 522 |
|
|
2023
Q3 | $2.15M | Buy |
+19,155
| New | +$2.43M | ﹤0.01% | 471 |
|
|
2023
Q1 | – | Sell |
-15,846
| Closed | -$2.02M | – | 987 |
|
|
2022
Q4 | $2.02M | Sell |
15,846
-270,315
| -94% | -$31.4M | ﹤0.01% | 530 |
|
|
2022
Q3 | $29.9M | Buy |
286,161
+180
| +0.1% | +$19.8K | 0.06% | 237 |
|
|
2022
Q2 | $30M | Sell |
285,981
-4,500
| -2% | -$534K | 0.05% | 232 |
|
|
2022
Q1 | $36.7M | Buy |
290,481
+43,620
| +18% | +$5.26M | 0.05% | 245 |
|
|
2021
Q4 | $30.8M | Sell |
246,861
-44,816
| -15% | -$5.87M | 0.05% | 214 |
|
|
2021
Q3 | $42.1M | Buy |
291,677
+39,567
| +16% | +$5.82M | 0.08% | 186 |
|
|
2021
Q2 | $39.1M | Buy |
252,110
+211,716
| +524% | +$34.3M | 0.08% | 194 |
|
|
2021
Q1 | $6.27M | Sell |
40,394
-198,229
| -83% | -$30.7M | 0.01% | 341 |
|
|
2020
Q4 | $35.2M | Buy |
+238,623
| New | +$33.7M | 0.08% | 192 |
|
|
2020
Q1 | – | Sell |
-59
| Closed | -$9K | – | 775 |
|
|
2019
Q4 | $9K | Buy |
+59
| New | +$8.14K | ﹤0.01% | 616 |
|
|
2019
Q3 | – | Sell |
-2,157
| Closed | -$203K | – | 767 |
|
|
2019
Q2 | $203K | Buy |
+2,157
| New | +$253K | ﹤0.01% | 542 |
|
|
2017
Q1 | – | Sell |
-337,813
| Closed | -$33.6M | – | 800 |
|
|
2016
Q4 | $33.6M | Buy |
+337,813
| New | +$36.2M | 0.06% | 240 |
|
|
2016
Q2 | – | Sell |
-165,406
| Closed | -$28.8M | – | 746 |
|
|
2016
Q1 | $28.8M | Sell |
165,406
-147,312
| -47% | -$14.3M | 0.07% | 200 |
|
|
2015
Q4 | $31.2M | Buy |
312,718
+28,060
| +10% | +$2.75M | 0.13% | 143 |
|
|
2015
Q3 | $26.1M | Sell |
284,658
-712,558
| -71% | -$71.4M | 0.11% | 163 |
|
|
2015
Q2 | $106M | Buy |
997,216
+86,492
| +9% | +$9.57M | 0.36% | 75 |
|
|
2015
Q1 | $104M | Buy |
910,724
+517,773
| +132% | +$59.1M | 0.39% | 73 |
|
|
2014
Q4 | $43.2M | Buy |
392,951
+309,513
| +371% | +$32.6M | 0.13% | 143 |
|
|
2014
Q3 | $8.15M | Buy |
83,438
+53,726
| +181% | +$5.28M | 0.03% | 315 |
|
|
2014
Q2 | $3M | Buy |
29,712
+29,073
| +4,550% | +$2.84M | 0.01% | 383 |
|
|
2014
Q1 | $59K | Buy |
+639
| New | +$58.9K | ﹤0.01% | 507 |
|
Other funds holding ZBH
VCM
VPM
1832 Asset Management's ZBH Position: Q1 2026 in Review
1832 Asset Management reduced its Zimmer Biomet (ZBH) stake by 6.6% in Q1 2026, selling an estimated $59.6K and leaving 9,150 shares worth $827K. The position accounts for ﹤0.01% of the portfolio, ranked #554.
1832 Asset Management first reported a position in ZBH in Q1 2014 and has held it in 30 quarters since. The position peaked at $106M in Q2 2015. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- 1832 Asset Management held 9,150 shares of Zimmer Biomet worth $827K as of Q1 2026.
- 1832 Asset Management sold 650 Zimmer Biomet shares in Q1 2026, an estimated $59.6K.
- Zimmer Biomet made up ﹤0.01% of 1832 Asset Management's portfolio in Q1 2026, its #554 holding.
- 1832 Asset Management first reported a position in Zimmer Biomet in Q1 2014 and has held it in 30 quarters since.
- 1832 Asset Management's Zimmer Biomet position peaked at $106M in Q2 2015.
- 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.